Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial cell membranes and intracellular macromolecules represent the primary structural and functional targets for a wide range of broad-spectrum antimicrobial agents, including antiseptics, disinfectants, and antimicrobial peptides (AMPs) (Creative Peptides, NIH). The microbial cell membrane is a critical target because it maintains cellular homeostasis and serves as a scaffold for essential metabolic enzymes; its disruption leads to immediate loss of membrane potential and leakage of vital ions and metabolites (Encyclopedia.pub, MDPI). Once the membrane is compromised, many of these agents can penetrate the cytoplasm to interact with intracellular macromolecules such as DNA, RNA, and ribosomes (ASM.org, ResearchGate). This secondary interaction inhibits genetic replication and protein synthesis, ensuring a rapid and comprehensive biocidal effect (Frontiers in Microbiology). Because these agents often employ a multi-hit mechanism affecting multiple essential components simultaneously, they are generally less prone to the rapid development of resistance compared to drugs that target a single specific enzyme or receptor (NIH, Frontiers in Microbiology).
Antimicrobial agents typically first interact with the microbial cell membrane via electrostatic or hydrophobic forces, causing pore formation or membrane rupture. This leads to the leakage of essential cytoplasmic contents and allows the drug to enter the cell, where it subsequently binds to and inactivates intracellular macromolecules such as DNA, RNA, and proteins, thereby inhibiting vital processes like replication, transcription, and translation.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell membranes and intracellular macromolecules.